SMi Source(TM) Projected to Hit Over One Million Views
Friday, August 13, 2021
SAN DIEGO, Aug. 5, 2021 /PRNewswire/ -- ScienceMedia announces SMi Source, the world's largest, mobile-enabled disease and clinical education resource for life sciences, will reach over one million views in 2021. Life science professionals access SMi Source on average every nine seconds of every workday throughout the year.
Life science professionals access SMi Source on average every nine seconds of every workday throughout the year. SMi Source improves on-the-job clinical competency by teaching complex medical science more efficiently and effectively. With over 16,000 microlearning modules and more than 400 full courses, SMi Source is used by pharmaceutical, biotech, and clinical research organizations across all divisions. It is the only disease and treatment microlearning library for the life sciences.
SMi Source uniquely combines Google-like search simplicity with accurate, reliable, and up-to-date medical education presented in an engaging YouTube-like format. Ensuring the quality and credibility that users have come to expect, the team of medical and clinical writers and graphics artists and include experts across therapeutic areas with a combined professional experience of just under one hundred years.
In early 2020, to support the ongoing effort of the pharmaceutical industry to fight the COVID-19 pandemic, ScienceMedia extended its online medical learning library to support the rapid education of key personnel. SMi Source's mobile-enabled, 24/7 accessibility afforded medical affairs professionals, clinical researchers, site staff, and commercial teams the ability to maximize our industry's impact during the public health crisis.
ScienceMedia's CEO and inventor of SMi Source, Mark Surles, states, "This is a very exciting time for our company. Having SMi Source in nine of the top twenty life science companies and growing is a significant achievement. The tenth anniversary release of SMi Source this fall further expands the accessibility and ease of navigation for all users. We are thrilled to see the growing usage as we continue to expand our medical and science library."
To experience SMi Source's vast microlearning library, sign up for an individual trial account.
About ScienceMedia
ScienceMedia improves clinical competency through innovative, multimedia. SMi Trial(TM) for site-based trials, and SMi Trial(D)((TM)) for decentralized or hybrid trials, mitigate clinical risk and decrease trial cost by optimizing study compliance throughout the lifetime of your clinical trial. SMi Source provides just-in-time and detailed information on diseases and clinical trial topics through a mobile-enabled, cloud-based medical science with16,000+ microlearning topics and 400+ full courses. For ongoing insight about proven clinical trial performance solutions, follow ScienceMedia via LinkedIn or our blog.
CONTACT:
Jennifer Pfau, jpfau@sciencemedia.com, 805-452-1795
View original content to download multimedia:https://www.prnewswire.com/news-releases/smi-source-projected-to-hit-over-one-million-views-301349223.html
SOURCE ScienceMedia
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
|
